// App-Quantinova.ai

: Safety and efficacy of pdVWF/FVIII in patients with von Willebrand disease undergoing surgery: Results from a non‐interventional multicentre study

Researchers

Presenter

  • K. Khair

Principal Investigators

  • M. von Depka Prondzinski

  • M. Sholzberg

  • M. Sol Cruz

  • K. Decker

  • Z. Cermkov

  • S. Werner

  • G. Rodgers

Medical Centers

  • Centre for Outcomes and Experience Research in Children's Health, Illness and Disability (ORCHID), Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom

  • Werlhof-Institute, Hannover, Germany

  • St. Michaels Hosp and Li Ka Shing Knowledge Inst, Univ of Toronto, Toronto, ON, Canada

  • Fundación Hemofilia de Salta, Salta, Argentina

  • Blood Centre, University Hospital, Ostrava, Czech Republic

  • Octapharma USA Inc., Hobocken

  • University of Utah, Salt Lake City, UT

Locations

  • United Kingdom

  • Germany

  • Canada

  • Argentina

  • Czech Republic

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Shire (pharmaceutical company)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved